Why is Altimmune, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
-65.51%
EBIT Growth (5y)
-198.17%
EBIT to Interest (avg)
-76.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.05
Sales to Capital Employed (avg)
0.00
Tax Ratio
0.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
63.77%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.75
EV to EBIT
-1.63
EV to EBITDA
-1.63
EV to Capital Employed
-10.94
EV to Sales
153.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-39.17%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Technical Movement
17What is working for the Company
NET SALES(HY)
At USD 0.03 MM has Grown at 160%
OPERATING CASH FLOW(Y)
Highest at USD -71.64 MM
NET PROFIT(HY)
Higher at USD -49.92 MM
ROCE(HY)
Highest at -42.75%
RAW MATERIAL COST(Y)
Fallen by -99.79% (YoY
CASH AND EQV(HY)
Highest at USD 605.08 MM
EPS(Q)
Highest at USD -0.18
-11What is not working for the Company
INTEREST(Q)
Highest at USD 1.07 MM
Here's what is working for Altimmune, Inc.
Net Sales
At USD 0.03 MM has Grown at 160%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -49.92 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -71.64 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
EPS
Highest at USD -0.18
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 605.08 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Raw Material Cost
Fallen by -99.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Altimmune, Inc.
Interest
At USD 1.07 MM has Grown at 21.92%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Interest
Highest at USD 1.07 MM
in the last five periods and Increased by 21.92% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)






